Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 17/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28489676 | 0.84 | TXNRD1 (0.53) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL3846429 | 0.83 | TXNRD1 (0.49) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL9794246 | 0.82 | TXNRD1 (0.53) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL13728584 | 0.81 | TXNRD1 (0.48) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL3410375 | 0.81 | TXNRD1 (0.41) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL3410384 | 0.81 | TXNRD1 (0.41) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL3410380 | 0.81 | TXNRD1 (0.41) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL335995 | 0.81 | TXNRD1 (0.49) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL5363195 | 0.81 | TXNRD1 (0.45) | TXNRD1GSRS1PR4MAPTS1PR1 | |
| SCHEMBL28489675 | 0.80 | TXNRD1 (0.57) | TXNRD1GSRS1PR4MAPTS1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7044987-B2 | 6-alkoxy-2,3-diaminopyridine couplers in which the amino radical in position 2 is a monosubstituted amino radical, and use of these couplers for dyeing keratin fibres | L'OREAL S.A. (FR) | 2006-05-16 | — | — | US | disclosed |
| EP-1551806-A1 | 6-ALKOXY-2,3-DIAMINOPYRIDINE COUPLERS AND USE OF SAID COUPLERS FOR THE DYEING OF KERATINOUS FIBRES | L'OREAL (FR) | 2005-07-13 | — | — | EP | disclosed |
| US-20050060814-A1 | Novel 6-alkoxy-2,3-diaminopyridine couplers in which the amino radical in position 2 is a monosubstituted amino radical, and use of these couplers for dyeing keratin fibres | L'OREAL S.A. (FR) | 2005-03-24 | — | — | US | disclosed |
| WO-2004031152-A1 | 6-ALKOXY-2,3-DIAMINOPYRIDINE COUPLERS AND USE OF SAID COUPLERS FOR THE DYEING OF KERATINOUS FIBRES | L'OREAL (FR) | 2004-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050060814-A1 | Novel 6-alkoxy-2,3-diaminopyridine couplers in which the amino radical in position 2 is a monosubstituted amino radical, and use of these couplers for dyeing keratin fibres | KRT18, QDPR, PYCR1 | TXNRD1 441/4885GLA 3416/4885GSR 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.